Africa Ready Malaria Screening

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,640

Participants

Timeline

Start Date

September 23, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2025

Conditions
Malaria
Interventions
DIAGNOSTIC_TEST

Immuno analytical assay

The eluted antibodies will be used in immuno-analytical assays, such as ELISA or Western blot, or surface-coated bead-based screening platforms using either recombinantly produced MSP119 fusion protein or synthetic peptides derived from MSP119 as antigens according to standard protocols.

Trial Locations (1)

GAR

Shai-Osudoku District Hospital, Dodowa

All Listed Sponsors
collaborator

Shai-Osudoku District Hospital

UNKNOWN

collaborator

Kumasi Technical University

UNKNOWN

collaborator

University of Rostock

OTHER

collaborator

University of Applied Sciences Bonn-Rhein-Sieg

UNKNOWN

collaborator

Hochschule Aalen

UNKNOWN

lead

University of Ghana

OTHER